Skip to main navigation

About
Pipeline
Clinical Trials
Partners
News
Investors
Investor Relations
Contact
Community

PRESS RELEASES

Webcast

TRACON Pharmaceuticals at H.C. Wainwright Global Life Sciences Conference

03/09/21 7:00 AM EST

Keyword Search

Year:

11/16/20

Summary Toggle TRACON Pharmaceuticals Announces Submission for Approval of Envafolimab (KN035) with the NMPA in China by its Corporate Partners Alphamab Oncology and 3D Medicines
Printer Friendly

PDF Version
11/10/20

Summary Toggle TRACON Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Corporate Update
Printer Friendly

PDF Version
11/03/20

Summary Toggle TRACON to Report Third Quarter 2020 Financial Results and Company Highlights on November 10, 2020
Printer Friendly

PDF Version
10/26/20

Summary Toggle TRACON Announces FDA Orphan Drug Designation for TRC102 in Malignant Glioma, Including Glioblastoma
Printer Friendly

PDF Version
09/21/20

Summary Toggle TRACON Pharmaceuticals Highlights Updated Envafolimab Clinical Results in MSI-H/dMMR Colorectal Cancer
Printer Friendly

PDF Version
09/10/20

Summary Toggle TRACON Pharmaceuticals to Present at the H.C. Wainwright 22nd Annual Global Investment Conference
Printer Friendly

PDF Version
09/03/20

Summary Toggle TRACON Pharmaceuticals to Present at the Wells Fargo Virtual Healthcare Conference
Printer Friendly

PDF Version
08/31/20

Summary Toggle TRACON Pharmaceuticals Announces Additional $5.0 Million Private Placement
Printer Friendly

PDF Version
08/27/20

Summary Toggle TRACON Pharmaceuticals Announces $5.0 Million Private Placement
Printer Friendly

PDF Version
08/17/20

Summary Toggle TRACON Pharmaceuticals Announces FDA Clearance of ENVASARC Pivotal Trial
Printer Friendly

PDF Version

Pagination

First page
Previous page
Page 1
Current page 2
Page 3
Page 4
…
Next page
Last page

Print Page
RSS Feeds
Email Alerts
Contact

4350 La Jolla Village Drive
Suite 800
San Diego, CA 92122

Phone: (858) 550-0780
Fax: (858) 550-0786
Email: info@traconpharma.com

About

Management
Board of Directors
Scientific Advisory Board

News

Press Releases
Publications

Pipeline

Envafolimab (KN035)
TRC102
TRC253

Partners

Contact

Clinical Trials

Investors

Investor Relations

Press Releases
Events & Presentations
Corporate Governance
Financials & Filings
Stock Information
- Historical Price Lookup
- Investment Calculator
Investor FAQ
Contact

Copyright © TRACON Pharmaceuticals, Inc. 2021